bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.02.13.580057

Variations in polarized trafficking of viral envelope proteins from insect-specific and insect-vectored viruses in insect midgut and salivary gland cells

Abstract

Systemic viral infection of insects typically begins with primary infection of midgut epithelial cells (enterocytes) and subsequent transit of virus in an apical-to-basal orientation through the polarized enterocytes into the hemocoel. In the case of insect-vectored viruses, a similar yet oppositely oriented process (basal-to-apical virus transit) occurs upon secondary infection of salivary glands, and is necessary for virus transmission to non-insect hosts. To examine this inversely oriented virus transit in these polarized tissues, we assessed the intracellular trafficking of two model viral envelope proteins (baculovirus GP64 and vesicular stomatitis virus glycoprotein, VSV G) in the midgut and salivary gland cells of the model insect, Drosophila melanogaster. Using transgenic Drosophila fly lines that inducibly express either GP64 or VSV G, we found that both proteins were trafficked basally in midgut enterocytes. In salivary gland cells, VSV G was trafficked to apical membranes in most but not all cells, whereas GP64 was trafficked consistently to basal membranes. We further examined the mechanism of polarized trafficking in midgut and salivary gland epithelia and found that a cytoplasmic YxxO motif in both VSV G and GP64 proteins is critical for basal trafficking of each envelope protein in midgut enterocytes, but dispensable for their trafficking in salivary gland epithelial cells. Using RNAi, we found that clathrin adapter protein complexes AP1 and AP3, as well as several Rab GTPases (Rab1, 4, 8, 10, 23, 30, and - 35), were involved in polarized VSV G trafficking in midgut enterocytes. Our results indicate that these viral envelope proteins encode the requisite information and require no other viral factors for appropriately polarized trafficking. In addition, they exploit tissue-specific differences in protein trafficking pathways to facilitate virus egress in the appropriate orientation for establishing systemic infections and vectoring infection to other hosts. Author SummaryViruses that use insects as hosts must navigate specific routes through the insects tissues to complete their life cycles. The routes may differ substantially depending on the life cycle of the virus. Some insect pathogenic viruses, such as baculoviruses, establish a systemic infection and this represents an endpoint in the infection cycle in the insect. In contrast, many insect-vectored viruses establish a systemic infection in the insect, but must also deliver infectious virus to the insects non-insect host. In both cases, the virus must first navigate through the midgut epithelium to establish a systemic infection, but insect-vectored viruses must also navigate through the salivary gland epithelium. Both midgut and salivary gland cells are polarized, and insect-vectored viruses appear to traffic in opposite directions in these two tissues. In this study, we asked whether two viral envelope proteins alone encode the signals necessary for polarized trafficking associated with their respective life cycles. Using two representative viral envelope proteins (VSV G and baculovirus GP64) and Drosophila as a model insect to examine tissue-specific polarized trafficking of viral envelope proteins, we identified one of the virus-encoded signals and several host proteins associated with regulating the polarized trafficking in the midgut epithelium.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hodgson, J. J., Chen, R. Y., Blissard, G., Buchon, N.. 2024-02-13. Variations in polarized trafficking of viral envelope proteins from insect-specific and insect-vectored viruses in insect midgut and salivary gland cells. https://doi.org/10.1101/2024.02.13.580057

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗